한글목차

세계의 바이오테크놀러지 시장은 2024년에 1조 4,500억 달러로 평가되었으며, 2030년까지 CAGR 12.85%로 성장하여 2조 9,900억 달러에 달할 것으로 예측됩니다.

바이오테크놀러지는 생물학적 시스템이나 공정을 응용하여 인간의 건강, 농업, 산업 공정을 촉진하는 제품이나 기술을 개발하는 분야입니다. 시장 확대를 뒷받침하는 주요 요인으로는 첨단 치료 및 진단 솔루션을 필요로 하는 만성질환 및 감염성 질환의 전 세계적 확산과 유전체학, 분자생물학, 유전공학의 지속적인 발전을 들 수 있습니다. 맞춤형 의료에 대한 수요 증가도 시장 발전에 큰 원동력이 되고 있습니다.

주요 시장 촉진요인

바이오테크놀러지 시장은 유전공학 및 유전자 편집 기술의 획기적인 발전으로 인해 크게 성장하고 있습니다. CRISPR과 같은 도구로 대표되는 이러한 발전은 유전물질의 정밀한 변형이 가능해져 질병의 근본 원인에 대한 치료에서 전례 없는 가능성을 제공하고 있습니다.

주요 시장 과제

대규모 연구개발 활동에 필요한 막대한 자본 투자는 세계 바이오테크놀러지 시장의 성장에 큰 장벽으로 작용하고 있습니다. 혁신적인 생물학적 시스템이나 공정의 개발은 제품이 상용화되기까지 오랜 기간 동안 많은 자금이 투입되어야 하는 경우가 많습니다.

주요 시장 동향

인공지능(AI)의 활용은 신약 후보물질 발굴, 후보물질 최적화, 임상 결과 예측 등의 프로세스를 가속화 및 효율화함으로써 신약개발 파이프라인에 혁명을 일으키고 있습니다. 이 기술을 통해 기존의 신규 치료제 시장 진입에 소요되는 시간과 비용을 절감할 수 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이오테크놀러지 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 용도별(바이오의약품, 바이오 IT, 바이오 산업, 바이오 농업)
  • 최종사용자별(바이오테크놀러지·제약 기업, 연구기관·연구소, 학술기관, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 바이오테크놀러지 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이오테크놀러지 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이오테크놀러지 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 바이오테크놀러지 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 바이오테크놀러지 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 바이오테크놀러지 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Novo Nordisk A/S
• Regeneron Pharmaceuticals Inc.
• Amgen, Inc.
• CSL Limited
• Gilead Sciences, Inc.
• Celgene Corporation
• Biogen Inc.
• Vertex Pharmaceuticals, Inc.
• Seagen Inc.
• Genmab A/S

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Biotechnology Market, valued at USD 1.45 Trillion in 2024, is projected to experience a CAGR of 12.85% to reach USD 2.99 Trillion by 2030. Biotechnology encompasses the application of biological systems and processes to develop products and technologies that advance human health, agriculture, and industrial processes. Key drivers supporting the market's expansion include the increasing global prevalence of chronic and infectious diseases, necessitating advanced therapeutic and diagnostic solutions, alongside continuous advancements in genomics, molecular biology, and genetic engineering. The growing demand for personalized medicine also provides substantial impetus for market development.

Key Market Drivers

The biotechnology market is significantly propelled by breakthroughs in genetic engineering and gene editing technologies. These advancements, exemplified by tools such as CRISPR, enable precise modifications to genetic material, offering unprecedented potential for treating diseases at their root cause. This has led to a rapid expansion in therapeutic development, moving beyond conventional small molecules and biologics. This momentum is clearly reflected in regulatory milestones, as according to RegMedNet, May 2025, FDA-Approved Cell and Gene Therapies, the US Food and Drug Administration approved nine cell and gene therapy products in 2024, signaling a robust pipeline translating into tangible patient solutions.

Key Market Challenges

The substantial capital investment necessitated by extensive research and development activities presents a considerable impediment to the growth of the global biotechnology market. Developing innovative biological systems and processes demands significant, long-term financial commitments, often over many years before a product can reach commercialization. This inherent financial burden acts as a barrier, particularly for smaller biotechnology firms, limiting their capacity to pursue novel therapeutic and diagnostic solutions. For larger entities, the high costs can lead to a more conservative investment strategy, focusing resources on fewer, higher-probability projects, which can slow the overall pace of innovation and restrict the diversity of product pipelines across the industry.

Key Market Trends

The adoption of artificial intelligence in drug discovery and development is revolutionizing the pharmaceutical pipeline by enhancing the speed and efficiency of identifying drug candidates, optimizing lead compounds, and predicting clinical outcomes. This technology reduces the time and cost traditionally associated with bringing new therapies to market. For instance, according to the Massachusetts Biotechnology Council, Massachusetts-headquartered biopharma companies collectively received $7.89 billion in venture capital funding in 2024, reflecting substantial investment in innovation that includes AI-driven methodologies. Further illustrating this trend, Bexorg, Inc. announced the completion of a $23 million Series A financing in October 2025, specifically aimed at advancing its integrated AI and whole-human brain platform for central nervous system drug discovery and development.

Key Market Players

• Novo Nordisk A/S
• Regeneron Pharmaceuticals Inc.
• Amgen, Inc.
• CSL Limited
• Gilead Sciences, Inc.
• Celgene Corporation
• Biogen Inc.
• Vertex Pharmaceuticals, Inc.
• Seagen Inc.
• Genmab A/S

Report Scope:

In this report, the Global Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Market, By Application:

• Biopharmaceuticals
• Bio-IT
• Bio- Industrial
• Bio-Agriculture

Biotechnology Market, By End User:

• Biotechnology & Pharmaceutical Companies
• Research Institutes & Laboratories
• Academic Institutions
• Others

Biotechnology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Market.

Available Customizations:

Global Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Biopharmaceuticals, Bio-IT, Bio- Industrial, Bio-Agriculture)
  • 5.2.2. By End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biotechnology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Biotechnology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Biotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End User

7. Europe Biotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End User
  • 7.3.2. France Biotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Biotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Biotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Biotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By End User

8. Asia Pacific Biotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End User
  • 8.3.2. India Biotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Biotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Biotechnology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Biotechnology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By End User

9. Middle East & Africa Biotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Biotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Biotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End User

10. South America Biotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Biotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Biotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biotechnology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novo Nordisk A/S
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Regeneron Pharmaceuticals Inc.
• 15.3. Amgen, Inc.
• 15.4. CSL Limited
• 15.5. Gilead Sciences, Inc.
• 15.6. Celgene Corporation
• 15.7. Biogen Inc.
• 15.8. Vertex Pharmaceuticals, Inc.
• 15.9. Seagen Inc.
• 15.10. Genmab A/S

16. Strategic Recommendations

17. About Us & Disclaimer